Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multinational Observational Uncontrolled Open Programme "The Use of TRIple Fixed-dose COmbination in the Treatment of arteriaL Hypertension: Opportunity for Effective BP Control With cOmbined Antihypertensive Therapy"

NCT03722524 is registered in ClinicalTrials.gov with Servier Russia as lead sponsor.

NCT NCT03722524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03722524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multinational Observational Uncontrolled Open Programme "The Use of TRIple Fixed-dose COmbination in the Treatment of arteriaL Hypertension: Opportunity for Effective BP Control With cOmbined Antihypertensive Therapy"
Lead sponsor
Servier Russia
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
July 17, 2019
Enrollment
1,247 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

arterial hypertension